Softwr

Research · head to head

Dotmatics vs STARLIMS

Dotmatics logo

Dotmatics

Research

Research informatics group behind GraphPad Prism, SnapGene, Geneious and LabArchives, now owned by Siemens

From
On request
Rated
-
Full reviewWebsite
STARLIMS logo

STARLIMS

Research

Laboratory information management from Abbott for regulated and public health labs

From
On request
Rated
-
Full reviewWebsite

The short version

  • Each has a real cost: Dotmatics the portfolio was assembled by acquisition and integration between the constituent products is uneven, so buying several Dotmatics brands does not deliver a single connected environment and often means the same manual export steps as before.; STARLIMS implementation is lengthy and outcome quality depends heavily on the partner doing the configuration
  • They diverge on capability: Dotmatics covers Dotmatics platform, STARLIMS covers Sample and specimen management.
  • Prices and features above were last checked on 31 August 2026.

Where they differ

Only the attributes on which Dotmatics and STARLIMS actually diverge.

Attributes where Dotmatics and STARLIMS differ
AttributeDotmaticsSTARLIMS
PlatformsWeb, Windows, macOS, On-premiseWeb, Windows, Cloud, On-premise

Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Research).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Dotmatics

  • Dotmatics platform
  • GraphPad Prism
  • SnapGene
  • Geneious Prime and Biologics
  • LabArchives
  • Flow cytometry tools
  • Protein Metrics
  • Siemens ownership

Only in STARLIMS

  • Sample and specimen management
  • Quality management
  • Instrument integration
  • Public health reporting
  • Regulatory compliance
  • Web and mobile access

What people use each for

The jobs each tool is most often brought in to do.

Dotmatics

  • A pharmaceutical company consolidating compound registration, assay data and biology screening onto one informatics layernot STARLIMS
  • A biotech that already owns Prism, SnapGene and Geneious separately and wants to understand what a group contract would covernot STARLIMS
  • A university licensing LabArchives across departments as an institutional electronic lab notebooknot STARLIMS
  • A biologics group needing sequence analysis, flow cytometry and proteomics tools from one supplier with a single procurement routenot STARLIMS

STARLIMS

  • Public health laboratories handling surveillance and outbreak investigationnot Dotmatics
  • Clinical laboratories needing regulated specimen tracking and reportingnot Dotmatics
  • Food safety and environmental testing laboratoriesnot Dotmatics
  • Multi-site laboratory networks standardising methods and specificationsnot Dotmatics

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Dotmatics

  • The portfolio was assembled by acquisition and integration between the constituent products is uneven, so buying several Dotmatics brands does not deliver a single connected environment and often means the same manual export steps as before.
  • The Siemens acquisition completed in July 2025 with stated revenue synergy targets, which usually translates into pressure to move individually bought desktop licences into larger platform agreements, and small buyers of a single Prism or SnapGene seat should expect that pressure at renewal.
  • Nothing about the enterprise platform is publicly priced, and even the individual applications are increasingly moved to subscription, so total cost across a research group is hard to establish before negotiation.
  • Each acquired product retains its own licence terms, support channel and release cycle, so an organisation using four Dotmatics brands manages four different renewal dates, entitlement models and support experiences.
  • Enterprise deployments require data migration and configuration services, and validated instances for regulated use add both cost and an ongoing customer revalidation duty after each release, so the informatics platform is a programme rather than a purchase.

STARLIMS

  • Implementation is lengthy and outcome quality depends heavily on the partner doing the configuration
  • Pricing is quote-based with no public reference, making early budget setting difficult
  • The breadth across laboratory types means some verticals get less development attention than others
  • Interface modernisation has lagged behind newer cloud-native laboratory platforms
  • Over-specified for small laboratories, where a lighter LIMS delivers most of the value for a fraction of the effort

Pricing, plan by plan

Dotmatics

On request
  • Dotmatics platform$undefined/year
    • Enterprise informatics platform priced per user per year on quotation
    • Chemistry and biology registration, assay data and ELN modules scoped separately
    • Implementation and data migration services quoted as a separate programme

STARLIMS

On request
  • STARLIMS$undefined/year
    • Sample management
    • Quality management
    • Instrument integration

Which should you pick?

Choose Dotmatics if

  • You need dotmatics platform.
  • You work on Web, Windows, macOS, On-premise.
  • You also want graphpad prism.
Dotmatics review

Choose STARLIMS if

  • You need sample and specimen management.
  • You work on Web, Windows, Cloud, On-premise.
  • You also want quality management.
STARLIMS review

Questions people ask

Is Dotmatics or STARLIMS better?
Neither clearly leads. Dotmatics starts at On request and STARLIMS at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Dotmatics or STARLIMS?
Dotmatics starts at On request and STARLIMS at On request.
Does Dotmatics or STARLIMS run on more platforms?
Dotmatics runs on Web, Windows, macOS, On-premise. STARLIMS runs on Web, Windows, Cloud, On-premise.
What is Dotmatics best used for?
Dotmatics is most often used for a pharmaceutical company consolidating compound registration, assay data and biology screening onto one informatics layer, a biotech that already owns prism, snapgene and geneious separately and wants to understand what a group contract would cover, a university licensing labarchives across departments as an institutional electronic lab notebook, a biologics group needing sequence analysis, flow cytometry and proteomics tools from one supplier with a single procurement route. Of those, a pharmaceutical company consolidating compound registration, assay data and biology screening onto one informatics layer and a biotech that already owns prism, snapgene and geneious separately and wants to understand what a group contract would cover are not what STARLIMS is typically brought in for.
What can Dotmatics do that STARLIMS cannot?
Dotmatics covers Dotmatics platform, GraphPad Prism, SnapGene, Geneious Prime and Biologics. STARLIMS covers Sample and specimen management, Quality management, Instrument integration, Public health reporting.

Answered from the vendors’ own pages

Dotmatics: Who owns Dotmatics?

Siemens, which completed a 5.1 billion dollar acquisition on 1 July 2025. Dotmatics now sits inside Siemens Digital Industries Software.

STARLIMS: Who owns STARLIMS?

Abbott. That gives it institutional weight in laboratory procurement and a natural relationship with Abbott diagnostic instruments.

Dotmatics: Is GraphPad Prism a Dotmatics product?

Yes. So are SnapGene, Geneious, LabArchives, FCS Express, OMIQ, Protein Metrics, SoftGenetics and nQuery.

STARLIMS: Where is it strongest?

Public health and clinical laboratories. Surveillance reporting, outbreak investigation and unpredictable specimen surges are different problems from pharmaceutical QC, and it handles them well.

Dotmatics: Do the products work together?

To varying degrees. They were acquired separately and integration across the portfolio is uneven, so verify the specific pair you care about before assuming it.

STARLIMS: What does it cost?

Not published. Enterprise licensing plus implementation, quoted on laboratory count, users and modules.

Dotmatics: Is enterprise pricing published?

No. The informatics platform is quoted per user per year with modules and services scoped separately.

STARLIMS: How does it compare to LabWare?

Both are enterprise LIMS with regulatory depth. LabWare is more dominant in pharmaceutical QC; STARLIMS has more presence in public health and clinical. Implementation partner quality matters more than the platform difference.

STARLIMS: What decides a successful implementation?

Configuration and validation quality, not platform features. Evaluations that compare feature lists rather than implementation approach are asking the wrong question.

Share

Related pages

More on Dotmatics

More on STARLIMS

Keep looking

Other head to heads